New lozenge aims to ease radiation mouth sores for hours
Symptom relief
Recruiting now
This phase 3 trial tests whether a lozenge called BupiZenge, which contains the long-acting painkiller bupivacaine, can relieve mouth pain from radiation therapy better than the standard lidocaine rinse. About 150 adults with head and neck cancer will be randomly assigned to one …
Phase: PHASE3 • Sponsor: OncoZenge AB • Aim: Symptom relief
Last updated Jul 15, 2026 00:00 UTC